Medical Foods for the management of Chronic Illness and their Regulations in India, US and European Union

  • Trapti Saxena G Pulla Reddy College of Pharmacy, Hyderabad, 500028, India
  • Sruthi Yadala G Pulla Reddy College of Pharmacy, Hyderabad, India 500028
  • Ausali Kavya Sri G Pulla Reddy College of Pharmacy, Hyderabad, India 500028
  • Pishati Manasa Reddy G Pulla Reddy College of Pharmacy, Hyderabad, India 500028
  • Monika Nijhawan Gokaraju Rangaraju College of Pharmacy, Hyderabad, India

Abstract

As many chronic illnesses are incurable and require repeated treatments, this problem contributes to long-term drug use. But when it comes to managing and treating chronic illnesses, medical foods can provide an alternative to natural medications. Medical foods are foods that have been particularly prepared to meet the unique dietary needs of people with specific illnesses. When it comes to therapeutic applications such as deglutition, dyspepsia, or eating disorders, they are crucial in providing patients with nutritional support. In addition, they significantly improve patients' quality of life by lowering drug use, averting problems that could result from an excessive reliance on pharmaceuticals, and saving treatment costs. Depending on the illness, medical foods' nutritional content can be adjusted and customized. They are exempt from laws pertaining to drugs since they are not drugs. Every medical food is created especially for the chronic condition in question. As a result, the purpose of this review is to clarify the use of medical foods for conditions such as Parkinson's, Alzheimer's, anxiety and sleep disorders, pain syndrome, cancer, congenital metabolic disorders, and diabetes mellitus, and to suggest their use as a dietary supplement for these long-term illnesses.

Keywords: Foods for specific medical purposes (FSMPs), Medical foods, Chronic diseases, Congenital metabolic disorders (CMDs), regulations, FDA, Food Safety and Standards Authority of India (FSSAI), Nutrition Labeling, European Food Safety Authority (EFSA)

Downloads

Download data is not yet available.

References

1. Ruthsatz M, Chen J, Wu C, Morck T. Foods for special medical purposes/medical foods: A global regulatory synopsis. Regulatory Focus. [Internet]. RAPS; 2022 Aug 31 [cited 2024 May 20]. Available from:
https://rapsprod.blob.core.windows.net/rapsk13/raps/media/news-images/feature%20pdf%20files/22-8_ruthsatz-et-al_r2_final.pdf
2. Thaipisuttikul P, Galvin JE. Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease. Clin Pract (Lond). 2012; Mar;9(2):199-209. doi:10.2217/cpr.12.3.
3. Meral H, Demirdöven A. The Use of Medical Foods to Fight Chronic Diseases: A Narrative Review. Journal of Agricultural Sciences (Tarim Bilimleri Dergisi). 2024; 30(3):424-435. DOI: 10.15832/ankutbd.1357154.
4. Ciampa BP, Reyes Ramos E, Borum M, Doman DB. The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders. Gastroenterol Hepatol (N Y). 2017 Feb;13(2):104-115.
5. Food Safety and Standards Authority of India (FSSAI). Guidance note on foods for special medical purposes (FSMP) [Internet]. FSSAI; 2020 Aug 28 [cited 2024 May 20]. Available from:
https://www.fssai.gov.in/upload/uploadfiles/files/Guidance_Note_FSMP_28_08_2020.pdf
6. Lewis, C., Jackson, M., Klesh, K., & Poliner, M. Medical foods and US regulations. Developing New Functional Food and Nutraceutical Products. 2017;407–416
https://doi.org/10.1016/B978-0-12-802780-6.00021-3.
7. Shiming Li, Chi-Tang Ho, Klaus W. Lange. Medical foods in USA at a glance, Journal of Future Foods. 2021;1(2):141-145.
https://doi.org/10.1016/j.jfutfo.2022.01.003.
8. Food for special medical purposes. European Commission, EUR-Lex [Internet]. EC; 2016 Jul 20 [cited 2024 May 20]. Available from:
https://food.ec.europa.eu/safety/labelling-and-nutrition/specific-groups/food-special-medical-purposes_en
9. European Parliament and Council of the European Union. Commission Implementing Regulation (EU) 2016/128 supplementing Regulation (EU) No 609/2013, European Commission, EUR-Lex [Internet]. EMA; 2021 Jul 15 [cited 2024 May 20]. Available from:
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32016R0128
10. European Parliament and Council of the European Union. Foods for special medical purposes. EUR-Lex [Internet]. EMA; 2021 May 24 [cited 2024 May 20]. Available from:
https://eur-lex.europa.eu/EN/legal-content/summary/foods-for-special-medical-purposes.html
11. European Parliament and Council of the European Union. Commission Notice on the classification of Food for Special Medical Purposes (2017/C 401/01), Official Journal of the European Union; EUR-Lex [Internet]. EMA; 2017 Nov 25 [cited 2024 May 20]. Available from:
https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52017XC1125(01)
12. Meral H, Demirdöven A. The Use of Medical Foods to Fight Chronic Diseases: A Narrative Review. Journal of Agricultural Sciences (Tarim Bilimleri Dergisi). 2024; 30(3):424-435. DOI: 10.15832/ankutbd.1357154
13. Sharma A, Bemis M & Desilets A R. Role of medium chain triglycerides (Axona®) in the treatment of mild to moderate Alzheimer’s disease. American Journal of Alzheimer's Disease & Other Dementias. 2014;29(5):409-414.
https://doi.org/10.1177/1533317513518650
14. Soininen H, Solomon A, Visser P J, Hendrix S B, Blennow K, Kivipelto M & LipiDiDiet Clinical Study Group. 36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease. Alzheimer's & Dementia. 2021;17(1):29-40.
https://doi.org/10.1002/alz.12172
15. Grossman S, Nathan J P, Siuzdak A, Liang J & Sprycha C. Prevagen®: Analysis of Clinical Evidence and Its Designation as a “# 1 Pharmacist Recommended Brand”. The Senior Care Pharmacist. 2022;37(8):335-338
16. Spence J, Chintapenta M, Kwon H I & Blaszczyk A T. A brief review of three common supplements used in Alzheimer's disease. The Consultant Pharmacist. 2017; 32(7):412-414.
https://doi.org/10.4140/TCP.n.2017.412
17. Shell W, Bullias D, Charuvastra E, May L A & Silver D S. A randomized, placebo-controlled trial of an amino acid preparation on timing and quality of sleep. American Journal of Therapeutics. 2010;17(2):133-139
https://doi.org/10.1097/MJT.0b013e31819e9eab
18. Shell W E, Pavlik S, Roth B, Silver M, Breitstein M L, May L & Silver D. Reduction in pain and inflammation associated with chronic low back pain with the use of the medical food theramine. American Journal of Therapeutics. 2016;23(6):e1353
https://doi.org/10.1097/MJT.0000000000000068
19. Taylor S S, Noor N, Urits I, Paladini A, Sadhu M S, Gibb C & Viswanath O. Complex regional pain syndrome: a comprehensive review. Pain and Therapy.2021;10(2):875-892.
https://doi.org/10.1007/S40122-021-00279-4
20. Ravasco P. Nutrition in cancer patients. Journal of Clinical Medicine. 2019;8(8):1211
https://doi.org/10.3390/jcm8081211
21. Imran M, Ghorat F, Ul-Haq I, Ur-Rehman H, Aslam F, Heydari M & Rebezov M. Lycopene as a natural antioxidant used to prevent human health disorders. Antioxidants. 2020;9(8):706
https://doi.org/10.3390/antiox9080706
22. Liu Z, Ren Z, Zhang J, Chuang C C, Kandaswamy E, Zhou T & Zuo L. Role of ROS and nutritional antioxidants in human diseases. Frontiers in Physiology. 2018;9:477
https://doi.org/10.3389/FPHYS.2018.00477/FULL
23. Chen Q H, Wu B K, Pan D, Sang L X & Chang B. Beta-carotene and its protective effect on gastric cancer. World Journal of Clinical Cases. 2021;9(23):6591.
https://doi.org/10.12998/wjcc.v9.i23.6591
24. Rocha J C, Bausell H, Bélanger-Quintana A, Bernstein L, Gökmen-Özel H, Jung A & Heddrich-Ellerbrok M. Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase. Molecular Genetics and Metabolism Reports. 2021;28:100771.
https://doi.org/10.1016/j.ymgmr.2021.100771
25. Dipasquale V, Serra G, Corsello G & Romano C. Standard and specialized infant formulas in Europe: making, marketing, and health outcomes. Nutrition in Clinical Practice. 2020;35(2):273-281.
https://doi.org/10.1002/ncp.10261
26. Van Calcar S. Tetrahydrobiopterin Therapy for Phenylketonuria. In L E Bernstein, F Rohr & J R Helm (Eds.), Nutrition Management of Inherited Metabolic Diseases, Springer, New York. 2022; pp. 127–151.
27. Lubbe W. Clinicians guide for cue‐based transition to oral feeding in preterm infants: An easy‐to‐use clinical guide. Journal of Evaluation in Clinical Practice. 2018;24(1):80-88.
https://doi.org/10.1111/jep.12721
28. Gao L, Lin L, Shan N, Ren C Y, Long X, Sun Y H & Wang L. The impact of omega-3 fatty acid supplementation on glycemic control in patients with gestational diabetes: a systematic review and meta-analysis of randomized controlled studies. The Journal of Maternal Fetal & Neonatal Medicine. 2020;33(10):1767-1773.
https://doi.org/10.1080/14767058.20
29. Moore M D. Food as medicine: diet, diabetes management, and the patient in twentieth century Britain. Journal of the History of Medicine and Allied Sciences. 2018;73(2):150-167.
https://doi.org/10.1093/jhmas/jry008
30. Torres N, Avila-Nava A, Medina-Vera I & Tovar A R. Dietary fiber and diabetes. Science and Technology of Fibers in Food Systems. 2020;201-218.
https://doi.org/10.1007/978-3-030-38654-2_9.
31. Awuchi C G. Medicinal plants: the medical, food, and nutritional biochemistry and uses. International Journal of Advanced Academic Research. 2019;5(11):220-241.
Statistics
310 Views | 316 Downloads
How to Cite
1.
Saxena T, Yadala S, Sri AK, Reddy PM, Nijhawan M. Medical Foods for the management of Chronic Illness and their Regulations in India, US and European Union. Int J Drug Reg Affairs [Internet]. 2024Sep.15 [cited 2026Jan.31];12(3):13-2. Available from: https://www.ijdra.com/index.php/journal/article/view/684